At Maks BioSolutions, we believe in building strong, transparent, and value-driven partnerships with organizations that share our mission: to improve access to life-saving therapies across the GCC and MENA regions.
Whether you’re a global manufacturer, a healthcare provider, or a government procurement body, our partnership model is built to deliver compliance, quality, and long-term growth.
We are proud to be a trusted supplier through NUPCO since 2020, supporting Saudi Arabia’s public health ecosystem with compliant and responsive product delivery.
What we provide:
Tender registration and product prequalification
Supply assurance planning
Regulatory support and MoH engagement
Post-market traceability and safety updates
for primary immune deficiencies, autoimmune, and neurological disorders
for surgical recovery, liver disease, burns, and shock management
Please reach out to us regarding your questions or anything.
Answers to common questions about our products, services, and regulatory support across the GCC and MENA regions.
We specialize in Immunoglobulin (IVIG) and Human Albumin (5% and 20%), both essential in critical care, immune deficiencies, liver disease, and surgical recovery.
Yes. All products are SFDA-registered and supplied through NUPCO-approved channels. We ensure full regulatory compliance and documentation with every shipment.
Absolutely. We are experts in regulatory affairs, covering product registration, import licensing, and post-market surveillance for GCC and MENA regions.
We have been supplying plasma products through NUPCO tenders since 2020, making us a trusted and experienced vendor for Saudi Arabia’s central procurement and logistics hub. Our products are pre-approved and regularly delivered under national frameworks.